Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer

J Clin Invest. 2019 Jun 3;129(6):2595. doi: 10.1172/JCI129688. Epub 2019 Jun 3.

Authors

Holbrook E Kohrt, Roch Houot, Kipp Weiskopf, Matthew J Goldstein, Ferenc Scheeren, Debra Czerwinski, A Dimitrios Colevas, Wen-Kai Weng, Michael F Clarke, Robert W Carlson, Frank E Stockdale, Joseph A Mollick, Lieping Chen, Ronald Levy

No abstract available

Publication types

Retraction of Publication

Grants and funding

UL1 TR001863/TR/NCATS NIH HHS/United States